Rocket Pharmaceuticals

At Rocket, we value individuals who bring creativity, compassion, and passion for helping others to the table. Together, we are actively recruiting team members whose exceptional abilities and unwavering commitment will further our mission to seek #GeneTherapy cures. We’re highlighting the Associate Vice President, Quality Control position. Watch to learn more. Looking to #ElevateYourCareer? If your background and interests align with this position, we invite you to apply. We also encourage you to explore a variety of compelling openings at Rocket, with 20+ positions available across different departments, here: https://lnkd.in/dhqd7W-3. #Recruitment #NowHiring #JobPosting #OpenPositions

#TeamRocket believes in fostering an environment where all ideas are welcome, and the opinion of every team member is valued. We recently asked Madeline Doyle, Research Associate, to share her perspective on career development at Rocket. To learn more about Rocket and our passion, creativity, and commitment to patients, click here: https://lnkd.in/exrgX9Pj. #CompanyValues #CompanyCulture

The 21st Global CVCT Forum is kicking off today in Washington, DC—bringing together experts to explore the latest in cardiovascular gene therapy trials, scientific challenges, and emerging opportunities.  #TeamRocket is deeply committed to advancing #GeneTherapy research for inherited cardiovascular conditions. Chief Medical & Gene Therapy Officer, Jonathan Schwartz, will share insights in three sessions throughout #CVCT2024, highlighting the development of our three programs targeting cardiac conditions. Check out the full program here: http://globalcvctforum.com. #RareDiseases #CardiovascularInnovation

We’re heading to San Diego, California, for the 66th American Society of Hematology Annual Meeting! Our team is honored to join leading researchers working to advance cutting-edge science for #BloodDisorders. Visit #TeamRocket at Booth 3409, and be sure to check out our three posters showcasing research for severe LAD-I and PKD. Swipe right to learn more about our presence at #ASH ➡️

Generosity is one of the four core values that guide #TeamRocket every day. This #GivingTuesday, we’re shining a spotlight on an organization that is truly making a difference in people’s lives. Rise, a center for social support in central New Jersey, is dedicated to helping individuals and families overcome challenges and unlock their full potential. Through a range of services and community partnerships, RISE is empowering those in need to build brighter futures. Recently, we had the opportunity to organize a food drive to support our local community, ensuring more of our neighbors could enjoy a warm and fulfilling #Thanksgiving. Learn more about RISE and how you can get involved: http://njrise.org. #CompanyCulture #GiveBack #CommunityImpact

This #Thanksgiving, #TeamRocket is filled with gratitude for the incredible people dedicated to seeking #GeneTherapy cures for patients with rare and devastating diseases. Wishing everyone a warm and joyous Thanksgiving! #Gratitude #RareDiseases

#DidYouKnow that awareness of your family’s health history – and sharing it with your health care providers – can help you understand more about your health risks and treatment options? #TeamRocket understands the importance of knowing your family’s health history and we encourage you to use #FamilyHealthHistoryMonth to make sure your family’s health history is current. #FamilyHealth #HealthHistory #FamilyHealthHistory

#TeamRocket is proud to be named as one of The Healthcare Technology Report's Top 100 Healthcare Companies of 2024. We are humbled by this recognition and inspired to work toward a future where #DNAIsNoLongerDestiny. Learn more: https://lnkd.in/gdphXRAS.

Fifty-five peer-reviewed publications over more than two decades, and as of yesterday, I’m finally part of a New England Journal of Medicine authorship team for our Danon Disease Phase 1 long-term results. It’s partly patience rewarded, but mostly the result of a very dedicated group of colleagues and collaborators seeking to advance medicine over the past six years at Rocket Pharmaceuticals. And the power of #GeneTherapy that we believe can address life-threatening diseases at their root cause to transform lives.   Looking forward to taking each of these programs across the finish line and writing a new chapter in the era of precision medicine.   https://lnkd.in/ehM8EUib